Bristol-Myers Squibb Co.

BMYNYSE • USD
ThemeHealthcare - Oncology›Immunotherapy & Immuno-Oncology
54.95 USD
↘ 2.23 (3.90%)AT CLOSE (11:59 AM EDT)
54.98
↗ 0.03 (0.06%)
POST MARKET (AS OF 08:13 PM EDT)
Post Market
AS OF 08:13 PM EDT
54.98
↗ 0.03 (0.06%)
🔴Market: CLOSED
Open?$57.40
High?$57.45
Low?$54.71
Prev. Close?$57.18
Volume?20.6M
Avg. Volume?10.8M
VWAP?$55.10
Rel. Volume?1.91x
Bid / Ask
Bid?$54.97 × 200
Ask?$55.00 × 200
Spread?$0.03
Midpoint?$54.99
Valuation & Ratios
Market Cap?112.2B
Shares Out?2.0B
Float?2.0B
Float %?99.9%
P/E Ratio?15.42
P/B Ratio?5.59
EPS?$3.56
Dividend?4.52%
Ex-Dividend?N/A

Bristol-Myers Squibb Co. (BMY) trades at $55.00 per share. Technicals currently rate "Strong Sell" while our fundamental analysis reads "Neutral". Key drivers include exceptional Return on Equity (36.3%) and a bullish Golden Cross on the moving averages. On the valuation side, BMY appears attractively valued relative to sector peers across key multiples.

Technical & fundamental data as of Jun 1, 2026.

News
Profile
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
Themes
Healthcare - Oncology›Immunotherapy & Immuno-OncologyBiotech - Drug Development›Immunology & Autoimmune
Employees
32.5K
Market Cap
116.8B
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.bms.com
Listed
1952-06-23
Address
ROUTE 206 AND PROVINCE LINE ROAD
PRINCETON, NJ 08543
Phone: (609) 252-4621
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
77
Z-Score?
50
Momentum?
35
Short Sent.?
48
Piotroski F-Score?6/9Mixed
Altman Z-Score?2.40Grey
Confidence?73%Moderate
Full Fundamental Analysis →
Short InterestModerate
Short % of Float?1.80%Low
Short Interest?36.7M
Days to Cover?3.5
Free Float2.0B
Avg Daily Volume10.4M
Settlement Date2026-05-15
Financial Health
Current Ratio?1.42Adequate
Quick Ratio?1.28Adequate
Cash Ratio?0.50Adequate
Debt/Equity?2.22High
ValuationATTRACTIVELY VALUEDvs 10 peers + S&P 500
Score
89/100
P/E?
Peers
90
S&P
79
15.4CHEAP▾
P/B?
Peers
80
S&P
33
5.59FAIR▾
P/S?
Peers
100
S&P
60
2.31CHEAP▾
P/FCF?
Peers
100
S&P
90
9.4CHEAP▾
EV/EBITDA?
Peers
90
S&P
75
10.9CHEAP▾
EV/Sales?
Peers
100
S&P
60
3.03FAIR▾
Returns & Efficiency
ROE?
Peers
56
S&P
84
36.3%STRONG▾
ROA?
Peers
40
S&P
68
8.4%STRONG▾
Cash Flow & Enterprise
FCF?$11.9B
Enterprise Value?$147.1B
Fundamentals ratios updated end of day
MarketsMoversWatchlist